FDA Brief

Warning letters Drugs

FDA warning letter to

Eugia Pharma Specialities Limited

Issued Aug 15, 2024Posted Aug 20, 2024Center for Drug Evaluation and Research (CDER)

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Eugia Pharma Specialities Limited's FDA history

  1. Eugia Pharma Specialities Limited

    FDA warned Eugia Pharma Specialities that flawed aseptic line design and poor aseptic practices at its Kolthur Village plant risk contaminating sterile injectables.

    High risk

Full company page